Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.860
-0.060 (-2.05%)
Sep 25, 2026, 4:00 PM EDT - Market closed
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $238.55 million as of September 25, 2026. Its market cap has increased by 77.25% in one year.
Market Cap
238.55M
Enterprise Value
223.38M
1-Year Change
77.25%
Ranking
Category
Stock Price
$2.86
ChartMarket Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $238.55M, a decrease of -54.45%. That is a compound annual growth rate of -14.59%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 238.55M | 233.15% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Palisade Bio | 252.69M |
| AC Immune | 250.56M |
| Camp4 Therapeutics | 245.99M |
| Lyell Immunopharma | 241.38M |
| MacroGenics | 238.24M |
| Yarrow Bioscience | 237.63M |
| Sionna Therapeutics | 236.46M |
| ProQR Therapeutics | 232.85M |